Cogent Biosciences is a dynamic biotechnology leader focused on the development of precision therapies designed to address the underlying causes of serious diseases. By targeting specific genetic drivers, the company aims to provide more effective treatment options for patients whose needs have historically gone unmet.
Operating at the intersection of clinical development and innovative research, Cogent maintains a dual-presence across Massachusetts and Colorado. Their culture is defined by a commitment to scientific integrity and a shared mission to push the boundaries of what is possible in modern medicine, making it an ideal destination for researchers and professionals passionate about patient impact.